SCHEMBL1415339

SCHEMBL1415339

CS(=O)(=O)c1cc2nc(-n3cc(C(=O)O)cn3)[nH]c2cc1Cl

nearest known ligand 0.92

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 20/20 0.92

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1193190 0.96 EGLN1 (1.00) EGLN1
SCHEMBL1193496 0.86 EGLN1 (1.00) EGLN1
SCHEMBL1192802 0.86 EGLN1 (1.00) EGLN1
SCHEMBL12876162 0.86 EGLN1 (0.78) EGLN1
SCHEMBL1192446 0.85 EGLN1 (0.92) EGLN1
SCHEMBL1193299 0.85 EGLN1 (1.00) EGLN1
SCHEMBL1192914 0.85 EGLN1 (0.92) EGLN1
SCHEMBL1192823 0.85 EGLN1 (0.93) EGLN1
SCHEMBL1192978 0.84 EGLN1 (1.00) EGLN1
SCHEMBL12875906 0.84 EGLN1 (0.82) EGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2294066-A1 BENZOIMIDAZOLES AS PROLYL HYDROXYLASE INHIBITORS Janssen Pharmaceutica, N.V. (BE) 2011-03-16 EP disclosed
WO-2009134750-A1 BENZOIMIDAZOLES AS PROLYL HYDROXYLASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2009-11-05 WO disclosed